EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | - |
| FY24 | DKK 21.5B | DKK 7.8B |
| FY23 | DKK 16.5B | DKK 4.4B |
| FY22 | DKK 14.5B | DKK 5.5B |
| FY21 | DKK 8.4B | DKK 3B |
| FY20 | DKK 10.1B | DKK 4.8B |
| FY19 | DKK 5.4B | DKK 2.2B |
| FY18 | DKK 3B | DKK 1.5B |
| FY17 | DKK 2.4B | DKK 1.1B |
| FY16 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | - | - |
| FY24 | 31.1% | 36.4% |
| FY23 | 32.3% | 26.4% |
| FY22 | 43.2% | 37.6% |
| FY21 | 35.1% | 35.1% |
| FY20 | 62.4% | 47.1% |
| FY19 | 49.2% | 40.4% |
| FY18 | 45.6% | 48.7% |
| FY17 | 56.8% | 46.7% |
| FY16 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | DKK 7.6B |
| FY23 | DKK 7B |
| FY22 | DKK 3.6B |
| FY21 | DKK 2B |
| FY20 | DKK 6.1B |
| FY19 | DKK 1.2B |
| FY18 | DKK 943M |
| FY17 | DKK 1.5B |
| FY16 | - |
- Genmab
- Healthcare median
Show the numbers
| Year | Genmab | Healthcare median |
|---|---|---|
| FY25 | - | −63.2% |
| FY24 | 36.4% | −86.4% |
| FY23 | 26.4% | −123.6% |
| FY22 | 37.6% | −138.2% |
| FY21 | 35.1% | −139.8% |
| FY20 | 47.1% | −143.7% |
| FY19 | 40.4% | −143.3% |
| FY18 | 48.7% | −173.4% |
| FY17 | 46.7% | −166.7% |
| FY16 | - | −173.8% |